Aquestive Therapeutics, Inc. 10-Q filing
Filed 2025-08-11 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001398733-25-000013
- Form type
- 10-Q
- CIK
- 0001398733
- Primary document
- https://www.sec.gov/Archives/edgar/data/1398733/000139873325000013/aqst-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aquestive Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $18.7M | - | - |
| Cost Of Revenue | $8.2M | - | - |
| Operating Income | $-30.7M | - | - |
| Net Income | $-36.5M | - | - |
| Eps Basic | -0.37 | - | - |
| Eps Diluted | -0.37 | - | - |
| Cash And Equivalents | $60.5M | - | - |
| Total Assets | $93.7M | - | - |
| Total Liabilities | $166.3M | - | - |
| Shareholders Equity | $-72.6M | - | - |
| Operating Cash Flow | $-31.3M | - | - |
| Capital Expenditures | $242,000 | - | - |